Discovery of fluorinated 2‑Styryl 4(3H)-quinazolinone as potential therapeutic hit for oral cancer
- 2 February 2023
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 81, 117193
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The chemistry and pharmacology of privileged pyrroloquinazolinesMedChemComm, 2014
- Discovery of Biarylaminoquinazolines as Novel Tubulin Polymerization InhibitorsJournal of Medicinal Chemistry, 2014
- Synthesis of quinazolinones from anthranilamides and aldehydes via metal-free aerobic oxidation in DMSOTetrahedron Letters, 2014
- Optimization of 4-(N-Cycloamino)phenylquinazolines as a Novel Class of Tubulin-Polymerization Inhibitors Targeting the Colchicine SiteJournal of Medicinal Chemistry, 2014
- XenoSite: Accurately Predicting CYP-Mediated Sites of Metabolism with Neural NetworksJournal of Chemical Information and Modeling, 2013
- Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-aminoalkoxy-quinazolines.Journal of Medicinal Chemistry, 2010
- Pharmacotherapy of head and neck squamous cell carcinomaExpert Opinion on Pharmacotherapy, 2009
- Global epidemiology of oral and oropharyngeal cancerOral Oncology, 2009
- Current concepts for the management of head and neck cancer: ChemotherapyOral Oncology, 2009
- Fluorine in medicinal chemistryChemical Society Reviews, 2007